1. and Statistical Tables for the Design of Clinical Trials, Blackwell Scientific Publications, Oxford, 1987.
2. ‘Post-marketing surveillance: how many patients?’ TIPS, 93–94 (April 1981).
3. A statistical methodology for postmarketing surveillance of adverse drug reaction reports
4. Drug Information Association. “Postmarketing Reporting of Adverse Reactions”, FDA Division of Epidemiology and Surveillance Workshop, Rockville, Maryland, 16th May 1988.
5. CONTINUOUS INSPECTION SCHEMES